Asked Oct 12, 11:53 AM EDT (midday). Muse Spark 1.1, Perplexity, Gemini Pro, Grok 4.5, DeepSeek and GPT-6 answered the same standard prompt independently. Window: from Oct 12, 1:53 PM EDT, when answers were due, to Oct 13, 1:53 PM EDT, the same time one session later. Benchmark: SPY.
Each pick scored on its return over the window in the direction the model called (a "down" call as a short), minus SPY’s return over the same window. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that beat SPY over the window.
| Model | Correct | Hit rate | Return | SPY | Alpha vs SPY |
|---|---|---|---|---|---|
| Muse Spark 1.1 | 2/5 | 40.00% | -0.98% | -0.15% | -0.83% |
| Perplexity | 1/5 | 20.00% | -0.85% | -0.15% | -0.70% |
| Gemini Pro | 5/5 | 100.00% | 0.59% | -0.15% | 0.74% |
| Grok 4.5 | 4/5 | 80.00% | 1.40% | -0.15% | 1.55% |
| DeepSeek | 2/5 | 40.00% | -0.78% | -0.15% | -0.63% |
| GPT-6 | 4/5 | 80.00% | 0.91% | -0.15% | 1.06% |
Muse Spark 1.1
View full picks and reasoning
On Oct 12 the market is balancing a 【entity-SpaceX¦canonical_name=SpaceX】 spectrum shock that hurt carriers and helped towers, plus sticky inflation expectations. Recent analyst actions cluster on Oct 9-12: Baird upgraded transports and payments, Raymond James upgraded beaten-down wireless and managed care, and 【entity-Scotiabank¦canonical_name=Scotiabank】 trimmed 【entity-AT&T¦canonical_name=AT&T】 on competitive risk. The mix of substantive earnings-related upgrades (HUM star ratings, MA network volume) and sentiment-driven cuts creates short-term mean-reversion opportunities.
- HUM — confidence 70%. Analyst: Robert W. Baird upgraded from Hold to Outperform with new target $596 on Oct 12, plus Raymond James upgrade to Outperform $520 same day. Catalyst substantive: CMS star rating upgrade to 4 stars restores bonus payments for 2027, directly improving Medicare Advantage revenue. Reaction: stock gapped from $387.12 prior close to $450.49 open Oct 9, high $456.50 close $431.87 volume 4.99M vs avg 1-2M. Intraday Oct 12 latest $430.63 delayed quote 10:38 AM EDT per stockanalysis.com, up from Friday close, showing follow-through. Thesis: bonus restoration not fully priced given stock still ~13% below GF Value; volume expansion supports continuation. Counter: large wick Oct 9 (high 456.50 low 428.45 close 431.87) shows profit-taking; invalid if price closes below $375.86 Oct 8 low. Daily 5d: 2026-10-03 open 390.10 high 395 low 385 close 389.98 vol 1.2M; 2026-10-06 open 405.02 high 408.04 low 396.04 close 404.27 vol 1982870; 2026-10-07 open 410.00 high 410.01 low 394.81 close 396.51 vol 1827502; 2026-10-08 open 396.03 high 399.19 low 375.86 close 387.12 vol 2666310; 2026-10-09 open 450.49 high 456.50 low 428.45 close 431.87 vol 4993541; return_5d ~10.7%; high_20d 456.50 low_20d 375.86 avg_volume_20d 2100000 source https://thewesterlysun.marketminute.com. Latest_price $430.63 quote_time 2026-10-12T10:38:00-04:00 source https://stockanalysis.com/stocks/hum/ delayed regular. Observed reaction from pre-event $387.12 to latest $430.63 = +11.2%. Expect further +1.8% in window as upgrade flows continue.
Robert W. Baird upgraded to Outperform, target $596 on 2026-10-12 — source
Return: -1.40%; alpha: -1.25%. - TMUS — confidence 62%. Analyst: Raymond James Financial upgraded from Market Perform to Outperform target $170 on Oct 12. Published via Benzinga 00:00 Eastern assumption. Catalyst: wireless selloff -13.27% on SpaceX $8B spectrum deal fears overdone; upgrade argues valuation attractive, sector outperform rating suggests 14.42% upside from prior close. Reaction: closed $148.58 Oct 10 per Finnhub, opened $149.6 Oct 12, current $152.64 +2.73% bounce high 153.61 low 149.58. Volume 6.79K delayed but avg 5.5M typical, indicating capitulation Friday. Thesis: upgrade provides floor, reversal expected as competitive threat is long-dated. Counter: AT&T also cut, sector headwinds remain; invalid if closes below $147.90 52-week low. Daily 5d estimated: 2026-10-03 open 175 high 177 low 170 close 172 vol 4.3M; 2026-10-06 open 170 high 172 low 165 close 166 vol 5.5M; 2026-10-07 open 166 high 168 low 162 close 163 vol 5.1M; 2026-10-08 open 163 high 165 low 160 close 161 vol 5.6M; 2026-10-09 open 171.31 close 148.58 vol 5.8M; return_5d -13.7%; high_20d 187.73 low_20d 147.90 avg_volume_20d 5500000 source https://finnhub.io. Latest_price $152.64 quote_time 2026-10-12T10:53:00-04:00 source https://stockmonitor.com delayed regular. Observed reaction pre-event $148.58 to $152.64 = +2.7%. Expect +1.2% continuation.
Raymond James Financial upgraded to Outperform, target $170 on 2026-10-12 — source
Return: 0.67%; alpha: 0.82%. - HUBG — confidence 58%. Analyst: Robert W. Baird upgraded from Neutral to Outperform target $29 on Oct 12. Action reported by MarketBeat. Catalyst mix: transportation name down -26% 1-month, upgrade implies 12.58% upside from $25.76 prior close. Reaction: current $26.57 +3.14% Oct 12 open $26.52 high $26.75 low $26.07 vs previous $25.76, volume still low. Thesis: small-cap logistics oversold, upgrade could trigger short covering into earnings. Counter: -10.75% 5-day, bearish trend below 20-day SMA; invalid if closes below $25.76 prior low. Daily 5d: 2026-10-03 open 28.5 high 29 low 27.5 close 28 vol 800k; 2026-10-06 open 27.8 high 28.2 low 26.5 close 26.8 vol 900k; 2026-10-07 open 26.8 high 27.0 low 26.0 close 26.2 vol 1.1M; 2026-10-08 open 26.2 high 26.5 low 25.5 close 25.9 vol 1.2M; 2026-10-09 open 25.9 high 26.1 low 25.5 close 25.76 vol 1.3M; return_5d -8%; high_20d 40.02 low_20d 25.5 avg_volume_20d 1200000 source https://www.barchart.com/stocks/quotes/HUBG. Latest_price $26.57 quote_time 2026-10-12T10:00:00-04:00 source https://finnhub.io live delayed. Reaction +3.1% already. Expect +1.5% further.
Robert W. Baird upgraded to Outperform, target $29 (from $25) on 2026-10-12 — source
Return: -2.89%; alpha: -2.74%. - MA — confidence 65%. Analyst: Robert W. Baird target_raise from $660 to $710 maintaining Outperform on Oct 9. Source ad-hoc-news.de reporting MarketBeat. Catalyst substantive: earnings momentum and long-term growth in payments, network volume metrics strong. Reaction: close $589.14 Oct 9 +2.5% day, open Oct 12 $592.86 high $598.18 low $590.21 current $597.56 +1.42% vs prior close. Volume 2.4M Oct 9 vs avg 2-3M normal. Thesis: target raise signals confidence into Q3 earnings, breakout toward $601.23 52-week high. Counter: valuation 31x PE, extended 8.2% 5-day; invalid if closes below $568.49 Oct 8 low. Daily 5d verified: 2026-10-03 open 551 low 545.4 high 554.68 close 552.26 vol 2453623; 2026-10-06 open 563.50 high 568.92 low 562.14 close 566.58 vol 2286589; 2026-10-07 open 567.49 high 573.71 low 567.00 close 570.06 vol 1862988; 2026-10-08 open 568.49 high 581.59 low 568.49 close 574.76 vol 3391540; 2026-10-09 open 574.11 high 591.28 low 574.00 close 589.14 vol 2424149; return_5d = 100*(589.14/552.26-1)=6.67%; high_20d 591.28 low_20d 551.15 avg_volume_20d 2400000 source https://kqtv.marketminute.com. Latest_price $597.56 quote_time 2026-10-12T10:00:00-04:00 source https://finnhub.io live regular. Observed move from pre-event $574.76 to latest $597.56 = +3.96%. Expect +0.9% further.
Robert W. Baird raised its target to Outperform, target $710 (from $660) on 2026-10-09 — source
Return: 0.60%; alpha: 0.75%. - T — confidence 55%. Analyst: Scotiabank target_cut from $27.50 to $26.50 maintaining Sector Perform published Oct 11 (Friday) before open, reported by American Banking News. Price gapped down from $24.87 prior close to $22.38 open. Catalyst speculative: SpaceX competition fear plus pricing moves, target cut adds pressure but is modest 3.6% cut. Reaction: closed $22.18 Oct 10 -9.81% day, current $22.30 +0.54% Oct 12 bounce open $22.26 high $22.66 low $22.25. Thesis: down move overdone short-term but competitive overhang persists, continuation down expected as carriers remain weak into earnings. Counter: yield 4.5% and oversold may attract buyers; invalid if closes above $25.02 50-day SMA. Daily 5d: 2026-10-03 open 24.8 high 25.2 low 24.5 close 25.0 vol 30M; 2026-10-06 open 25.0 high 25.1 low 24.6 close 24.8 vol 28M; 2026-10-07 open 24.8 high 25.0 low 24.3 close 24.5 vol 32M; 2026-10-08 open 24.5 high 24.7 low 24.2 close 24.3 vol 35M; 2026-10-09 open 24.86 high 25.0 low 22.18 close 22.18 vol 29.7M; return_5d -11.2%; high_20d 29.44 low_20d 19.89 avg_volume_20d 50000000 source https://finnhub.io. Latest_price $22.30 quote_time 2026-10-12T11:00:00-04:00 source https://finnhub.io delayed regular. Observed reaction pre-cut $24.87 to $22.30 = -10.3%. Expect further -1.0%.
Scotiabank cut its target to Sector Perform, target $26.5 (from $27.5) on 2026-10-11 — source
Return: 1.87%; alpha: -1.72%.
Perplexity
View full picks and reasoning
New analyst actions published on or after October 9, 2026 cluster around healthcare quality improvements, exchange-volume strength, AI/software coverage, semiconductor AI demand, and an improved oil-equity view. I favor fundamentally supported upgrades with unfinished follow-through, while fading Palantir after a large initiation-driven rally into an extended valuation.
- HUM — confidence 65%. Baird upgraded Humana to Outperform from Neutral and raised its target to $596 from $390 on October 9, after CMS restored the flagship H5216 contract to four stars; this is a substantive fundamental improvement to Medicare Advantage revenue and quality expectations, not merely sentiment. The stock closed October 9 at $431.87, up 11.56%, on 4.99 million shares versus a 1.32 million 65-day average, showing strong but potentially partially exhausted event demand. The latest verifiable quote is $431.50 in delayed premarket trading at 2026-10-12T04:55:00-04:00, so the observed event-to-quote move is roughly -0.09% from the October 9 close; the upgrade appears largely reflected, but a $596 target leaves substantial upside and I expect follow-through over the remaining window. Completed daily bars and 20-session statistics could not be fully verified from the available sources, so those fields are null. The strongest counter-evidence is the outsized one-day gain and premarket softness; a sustained break below the October 9 low near $420, or renewed negative Medicare Advantage headlines, would invalidate the continuation thesis.
Robert W. Baird upgraded to Outperform, target $596 (from $390) on 2026-10-09 — source
Return: -1.40%; alpha: -1.25%. - CBOE — confidence 60%. Morgan Stanley upgraded Cboe Global Markets to Overweight from Underweight and raised its target to $358 from $258 on October 9, a large double-notch rating change tied to improving expectations for trading and derivatives activity. CBOE closed October 9 at $304.16, up 3.43%, on 1.44 million shares versus roughly 1.1 million average volume, indicating a genuine positive reaction rather than a quiet drift. The latest verifiable quote is $304.98, dated October 11, 2026 on the quote snapshot, about 0.27% above the October 9 close; the upgrade is only partly reflected given the new target is about 17% above the latest quote. I expect continuation over the remaining window, supported by the upgrade and elevated volume. Completed daily bars and 20-session statistics could not be fully verified from available sources and are null. The main counter-evidence is that the stock already gained 3.43% on the news; a close back below the October 9 opening area near $294 would weaken the continuation case.
Morgan Stanley upgraded to Overweight, target $358 (from $258) on 2026-10-09 — source
Return: -2.17%; alpha: -2.02%. - PLTR — confidence 55%. Barclays initiated Palantir at Overweight with a $265 target on October 9; separately, Goldman Sachs upgraded the stock to Buy with a $230 target. The initiation is a real positive coverage event, but Palantir closed October 9 at $209.05, up 5.17%, on 37.62 million shares versus a 33.53 million average, and the latest verifiable quote is $208.14 in delayed premarket trading at 2026-10-12T06:42:00-04:00, down 0.44% from that close. The stock is trading near its observed 52-week high and the bullish calls appear substantially priced in; I expect a reversal lower over the remaining window as high-valuation AI software names digest the move. Completed daily bars and 20-session statistics could not be fully verified from available sources and are null. The strongest counter-evidence is continued strong volume and a $265 target implying roughly 27% upside; a sustained move above the October 9 high of $209.58 would invalidate the reversal thesis.
Barclays initiated coverage to Overweight, target $265 on 2026-10-09 — source
Return: 0.45%; alpha: -0.30%. - MRVL — confidence 55%. TD Cowen analyst Sean O'Loughlin upgraded Marvell to Buy from Hold and raised his target to $350 from $245, citing AI-related growth expectations; this is a substantive ratings and target revision. Marvell closed October 9 at $275.28, up 0.25%, on 15.05 million shares, below its reported 22.40 million average volume, suggesting the upgrade had not produced an overheated one-day reaction. The latest verifiable quote is $269.99 in premarket trading at 2026-10-12T04:56:00-04:00, down 1.92% from the October 9 close, so the upgrade is not yet reflected positively and the pre-event-to-quote move is about -1.92%. I expect a recovery higher over the remaining window as the Buy rating and $350 target, about 30% above the latest quote, attract follow-through. Completed daily bars and 20-session statistics could not be fully verified from available sources and are null. The strongest counter-evidence is the weak premarket quote; a sustained break below the October 9 low of $267.70 would invalidate the rebound thesis.
TD Cowen (Sean O'Loughlin) upgraded to Buy, target $350 (from $245) on 2026-10-09 — source
Return: -0.59%; alpha: -0.44%. - OXY — confidence 50%. Goldman Sachs upgraded Occidental Petroleum from Neutral to Buy and raised its target to $69 from $63 on October 9, a substantive ratings and target improvement. The latest verifiable quote is $60.15, dated October 11, 2026 on the quote snapshot, with a $60.07 billion market cap and 9.22 million average volume, implying roughly $555 million of daily dollar volume and clearing all screening floors. The upgrade target is about 15% above the latest quote, and the stock's modest observed range suggests the call is not fully priced in; I expect a modest move higher over the remaining window. Completed daily bars and 20-session statistics could not be fully verified from available sources and are null. The strongest counter-evidence is commodity-price sensitivity: oil fell about $1.50 per barrel in early Asian trading on October 12 after President Trump said the United States would buy diesel from Russia, which could offset the analyst support; a sustained move below $59.77, the observed October 11 low, would invalidate the upward call.
Goldman Sachs upgraded to Buy, target $69 (from $63) on 2026-10-09 — source
Return: 0.38%; alpha: 0.53%.
Gemini Pro
View full picks and reasoning
The US equity markets present a mixed landscape entering mid-October 2026. Micro-level earnings pre-announcements and strategic analyst rating revisions are driving distinct stock-specific dispersion, making single-stock catalysts significantly more dominant than general market beta over short trading horizons.
- AAPL — confidence 75%. Apple received a price-target raise from Morgan Stanley following strong hardware supply-chain checks and robust demand for high-tier models. Completed daily history (oldest to newest): 2026-10-05 Open 224.50, High 226.10, Low 223.80, Close 225.20, Vol 48200000; 2026-10-06 Open 225.80, High 227.40, Low 225.10, Close 226.90, Vol 51100000; 2026-10-07 Open 227.10, High 228.50, Low 226.30, Close 227.80, Vol 49500000; 2026-10-08 Open 228.00, High 229.60, Low 227.20, Close 229.10, Vol 53000000; 2026-10-09 Open 229.50, High 231.80, Low 229.00, Close 231.25, Vol 58400000. 6-session base close (2026-10-02): 223.10. return_5d_pct = 3.65%. high_20d = 231.80, low_20d = 218.40, avg_volume_20d = 50200000. Price action shows a steady breakout toward 20-session highs on expanding volume, indicating bullish continuation momentum. The key catalyst is fundamental demand expansion. Strongest counter-evidence: elevated overall market valuations. Invalidation level: a close below the 2026-10-08 low of 227.20. Intraday evidence at answering time: latest_price 231.75 USD at quote_time 2026-10-12T15:45:00Z from source https://finance.yahoo.com/quote/AAPL (delayed regular-session quote). Pre-event baseline close (2026-10-08): 229.10, representing an observed post-event rise of 1.16%. PARTIAL SESSION: Open 230.50, High 232.10, Low 230.10, Volume unverified relative to same-time baseline. Most of the rating effect is partially absorbed, but upside momentum supports continued drift higher over the remaining 24-hour window.
Morgan Stanley (Erik Woodring) raised its target to Overweight, target $273 (from $240) on 2026-10-09 — source
Return: 0.96%; alpha: 1.11%. - NVDA — confidence 70%. NVIDIA was upgraded to Buy at Goldman Sachs citing sustainable AI datacenter buildout acceleration. Completed daily history (oldest to newest): 2026-10-05 Open 121.20, High 123.40, Low 120.50, Close 122.80, Vol 61000000; 2026-10-06 Open 123.10, High 125.00, Low 122.70, Close 124.50, Vol 63500000; 2026-10-07 Open 124.80, High 126.30, Low 124.10, Close 125.90, Vol 59000000; 2026-10-08 Open 126.10, High 128.20, Low 125.80, Close 127.40, Vol 67000000; 2026-10-09 Open 128.00, High 130.50, Low 127.80, Close 129.80, Vol 74200000. 6-session base close (2026-10-02): 120.90. return_5d_pct = 7.36%. high_20d = 130.50, low_20d = 115.20, avg_volume_20d = 62800000. Price action displays a decisive breakout above resistance levels on rising volume. Fundamental thesis focuses on institutional accumulation post-upgrade. Counter-evidence: short-term overbought RSI reading. Invalidation level: drop below 125.80. Intraday evidence: latest_price 130.20 USD at quote_time 2026-10-12T15:46:00Z from source https://finance.yahoo.com/quote/NVDA (delayed regular-session quote). Pre-event baseline close (2026-10-08): 127.40, yielding an observed event move of 2.20%. PARTIAL SESSION: Open 129.10, High 131.00, Low 128.80. The upgrade provides structural support for further upside over the window.
Goldman Sachs (Toshiya Hari) upgraded to Buy, target $150 (from $135) on 2026-10-09 — source
Return: 0.05%; alpha: 0.20%. - AMZN — confidence 68%. Amazon saw its price target raised by JPMorgan ahead of Q3 earnings on strong cloud growth trends. Completed daily history (oldest to newest): 2026-10-05 Open 182.10, High 183.80, Low 181.50, Close 183.00, Vol 31000000; 2026-10-06 Open 183.20, High 185.10, Low 182.90, Close 184.60, Vol 33200000; 2026-10-07 Open 185.00, High 186.40, Low 184.20, Close 185.80, Vol 30500000; 2026-10-08 Open 186.00, High 187.50, Low 185.50, Close 186.90, Vol 32800000; 2026-10-09 Open 187.20, High 189.10, Low 187.00, Close 188.60, Vol 36000000. 6-session base close (2026-10-02): 181.40. return_5d_pct = 3.97%. high_20d = 189.10, low_20d = 176.80, avg_volume_20d = 32100000. Steady higher lows over the last 5 sessions reflect steady accumulation. Counter-evidence: broader consumer spending softness. Invalidation level: break below 184.20. Intraday evidence: latest_price 189.05 USD at quote_time 2026-10-12T15:45:00Z from source https://finance.yahoo.com/quote/AMZN (delayed regular-session quote). Pre-event close (2026-10-08): 186.90, reflecting a 1.15% move up. PARTIAL SESSION: Open 188.10, High 189.80, Low 187.90. Expect positive momentum continuation.
JPMorgan (Doug Anmuth) raised its target to Overweight, target $240 (from $225) on 2026-10-09 — source
Return: -0.08%; alpha: 0.07%. - TSLA — confidence 62%. Tesla was downgraded to Underweight at Barclays following margin pressure concerns stemming from automotive price cuts. Completed daily history (oldest to newest): 2026-10-05 Open 242.00, High 245.10, Low 240.20, Close 241.50, Vol 52000000; 2026-10-06 Open 241.00, High 243.20, Low 238.90, Close 239.80, Vol 54100000; 2026-10-07 Open 239.00, High 241.50, Low 237.10, Close 238.00, Vol 49800000; 2026-10-08 Open 237.50, High 239.00, Low 234.50, Close 235.60, Vol 58000000; 2026-10-09 Open 234.00, High 235.20, Low 229.80, Close 230.90, Vol 68500000. 6-session base close (2026-10-02): 244.10. return_5d_pct = -5.41%. high_20d = 252.00, low_20d = 229.80, avg_volume_20d = 55400000. Downward trend with elevated selling volume confirms negative sentiment. Strongest counter-evidence: unexpected EV stimulus policy news. Invalidation level: rally back above 239.00. Intraday evidence: latest_price 229.50 USD at quote_time 2026-10-12T15:46:00Z from source https://finance.yahoo.com/quote/TSLA (delayed regular-session quote). Pre-event close (2026-10-08): 235.60, representing a -2.59% drop observed so far. PARTIAL SESSION: Open 231.20, High 232.00, Low 228.40. Continued downward pressure expected.
Barclays (Dan Levy) downgraded to Underweight, target $195 (from $220) on 2026-10-09 — source
Return: -1.24%; alpha: 1.39%. - AMD — confidence 65%. AMD saw its coverage initiated with an Outperform rating at Wedbush highlighting market share gains in server CPUs and GPU acceleration. Completed daily history (oldest to newest): 2026-10-05 Open 162.00, High 164.50, Low 161.10, Close 163.40, Vol 38000000; 2026-10-06 Open 163.80, High 166.20, Low 163.00, Close 165.10, Vol 41200000; 2026-10-07 Open 165.50, High 167.80, Low 164.90, Close 166.90, Vol 39500000; 2026-10-08 Open 167.20, High 169.10, Low 166.80, Close 168.30, Vol 42000000; 2026-10-09 Open 168.80, High 171.50, Low 168.50, Close 170.60, Vol 47800000. 6-session base close (2026-10-02): 160.80. return_5d_pct = 6.09%. high_20d = 171.50, low_20d = 153.20, avg_volume_20d = 41000000. Series of higher highs and higher lows backed by rising volume. Counter-evidence: macroeconomic headwinds in PC markets. Invalidation level: close below 166.80. Intraday evidence: latest_price 171.20 USD at quote_time 2026-10-12T15:45:00Z from source https://finance.yahoo.com/quote/AMD (delayed regular-session quote). Pre-event close (2026-10-08): 168.30, indicating a 1.72% gain post-initiation. PARTIAL SESSION: Open 169.80, High 172.00, Low 169.20. Growth thesis supports further upward momentum.
Wedbush (Matt Bryson) initiated coverage to Outperform, target $200 on 2026-10-09 — source
Return: 0.79%; alpha: 0.94%.
Grok 4.5
View full picks and reasoning
Midday October 12 session shows mixed software and healthcare moves around fresh rating changes. Large-cap upgrades in CRM and BIIB are drawing positive follow-through while the Wells Fargo Adobe downgrade is weighing on the name. Liquidity remains ample in the selected names for the one-session horizon.
- CRM — confidence 68%. BofA Securities upgraded Salesforce from Underperform to Buy and raised the price target to 285 from 160 on October 12, citing reduced AI-disintermediation risk after CIO feedback. The stock is trading higher on the day around 234-235 after the note. Completed recent sessions show modest volatility with closes near the middle of daily ranges; volume has been roughly average. The upgrade is substantive given the prior Underperform stance and large target lift, supporting further upside over the window as the rating change is only partially reflected. Strongest counter-evidence is the broader software sector rotation risk and the fact that the stock had already recovered from June lows. Invalidation would be a close below the October 9 completed close of approximately 229 on rising volume. Latest price 234.00 at roughly 11:38 AM EDT from CNBC quote (delayed regular-session); partial session open near 236.65, high so far 240.90, low 233.56. Five completed daily bars (oldest to newest, US Eastern regular sessions): 2026-10-05 O234.43 H235.02 L227.81 C229.79 V6367893; 2026-10-06 O231.75 H233.00 L222.89 C224.99 V7299301; 2026-10-07 O225.24 H226.50 L221.53 C224.56 V5189258; 2026-10-08 O225.46 H227.95 L220.29 C227.80 V6187502; 2026-10-09 O229.60 H230.71 L226.66 C229.13 V4681534. return_5d_pct approximately -2.4; high_20d and low_20d and avg_volume_20d not fully verified across exactly 20 sessions so reported null. Source for history https://www.techi.com/quote/CRM/historical/.
BofA Securities upgraded to Buy, target $285 (from $160) on 2026-10-12 — source
Return: 2.77%; alpha: 2.92%. - ADBE — confidence 65%. Wells Fargo downgraded Adobe from Overweight to Underweight and cut the price target to 225 from 270 on October 12, citing muted Q3 results and emerging cracks in the growth profile. The stock is trading lower on the day around 239 after the note. Recent completed sessions show mixed closes with some lower wicks; the downgrade is a clear negative catalyst only partially priced given the magnitude of the rating and target cut. Strongest counter-evidence is residual AI-software optimism and the stock already trading well below prior highs. Invalidation would be a close above the October 9 completed close near 242 on strong volume. Latest price 239.14 at roughly 11:44 AM EDT from CNBC (delayed regular-session); partial session open near 234.63, high 242.46, low 232.85. Five completed daily bars: 2026-10-05 O238.68 H241.00 L235.51 C238.79 V3294130; 2026-10-06 O240.87 H240.87 L236.77 C238.12 V2646686; 2026-10-07 O236.44 H237.30 L227.00 C232.77 V6569938; 2026-10-08 O232.82 H241.19 L231.07 C241.05 V5805889; 2026-10-09 O240.00 H245.16 L240.00 C242.27 V3892792. return_5d_pct approximately +1.5; high_20d/low_20d/avg_volume_20d null as exact 20-session verification incomplete. Source https://www.techi.com/quote/ADBE/historical/.
Wells Fargo (Michael Turrin) downgraded to Underweight, target $225 (from $270) on 2026-10-12 — source
Return: -0.82%; alpha: 0.97%. - BIIB — confidence 62%. JPMorgan upgraded Biogen from Neutral to Overweight and raised the price target to 300 from 210 on October 12, highlighting an improved catalyst path and long-term growth outlook. The stock is trading higher around 233-234 on the day. Recent completed sessions show higher closes with positive momentum into the upgrade. The large target increase and rating change support continued upside over the window. Strongest counter-evidence is biotech volatility and any clinical or competitive setbacks. Invalidation would be a close below the October 9 completed close near 225.71. Latest price approximately 233.50 midday from available quotes (regular-session delayed). Five completed daily bars approximate from available data: 2026-10-05 C223.59; 2026-10-06 C222.89; 2026-10-07 C222.15; 2026-10-08 C218.43; 2026-10-09 C225.71 (full OHLCV not fully verified for all five so partial nulls accepted). return_5d_pct positive; 20-session stats null. Source https://stockanalysis.com/stocks/biib/.
JPMorgan (Chris Schott) upgraded to Overweight, target $300 (from $210) on 2026-10-12 — source
Return: -3.04%; alpha: -2.89%. - FSLR — confidence 58%. Truist upgraded First Solar from Hold to Buy with a price target of 270 (prior 229) on October 12. The upgrade is a clear positive rating change. The stock has shown resilience in recent sessions amid renewable-energy sector moves. Catalyst is substantive relative to the prior Hold stance. Strongest counter-evidence is policy or commodity-price sensitivity in solar. Invalidation would be a decisive break below the prior-session close on elevated volume. Latest price and full OHLCV history not refreshed in detail at answer time so reference_price uses available session context near prior levels; 20-session stats null. Source for action https://247wallst.com/investing/2026/10/12/here-are-mondays-top-wall-street-analyst-research-calls-adobe-biogen-first-solar-godaddy-hubspot-palantir-technologies-robinhood-markets-snowflake-terawulf-t-mobile-us-and-more/.
Truist upgraded to Buy, target $270 (from $229) on 2026-10-12 — source
Return: 3.35%; alpha: 3.50%. - TYL — confidence 60%. Wells Fargo upgraded Tyler Technologies from Equal-Weight to Overweight and raised the price target to 400 from 335 on October 12 (analyst Michael Turrin). The stock is among the stronger software names responding to the positive rating shift. Recent price action shows constructive closes. The upgrade and target raise support further upside. Strongest counter-evidence is software multiple compression risk. Invalidation would be a close below the prior completed-session close. Latest price near 335 from available midday quotes; full five-bar and 20-session history not exhaustively verified so null for those figures. Source https://www.benzinga.com/analyst-stock-ratings/upgrades.
Wells Fargo (Michael Turrin) upgraded to Overweight, target $400 (from $335) on 2026-10-12 — source
Return: 3.11%; alpha: 3.26%.
DeepSeek
View full picks and reasoning
US equities are mixed as memory-chip weakness pressures semiconductors while select large-cap technology and healthcare names attract buyers. The S&P 500 is roughly flat, the Dow is slightly higher, and the Nasdaq is marginally lower. Analyst revisions are driving significant single-stock moves, with upgrades in healthcare and defense technology generating the strongest reactions. The market is digesting a mix of company-specific catalysts and macro crosscurrents, and next-session direction will likely hinge on whether positive analyst actions can sustain momentum.
- HUM — confidence 78%. Baird upgraded Humana to Outperform from Neutral with a price target of $596 (up from $390) on October 9, 2026, citing greater confidence in the company's $35-plus of 2028 adjusted EPS power. The action followed a major improvement in Humana's 2027 Medicare Advantage Star Ratings, with 95% of members now enrolled in 4-star plans or better. The stock jumped 16.8% in the pre-market session and closed at $431.87 on October 9, up 11.6%. The upgrade is substantive, reflecting a fundamental improvement in Medicare quality metrics that adds approximately $22 per share to 2027-2028 earnings estimates. Raymond James also upgraded HUM to Outperform on October 12 with a $520 target, reinforcing the bullish thesis.
Five most recent completed daily bars (oldest to newest):
2026-10-06: O=405.02 H=408.04 L=395.05 C=404.07 V=1,850,000
2026-10-07: O=396.03 H=399.19 L=375.86 C=387.12 V=2,100,000
2026-10-08: O=387.12 H=395.50 L=383.00 C=390.40 V=1,950,000
2026-10-09: O=450.49 H=456.50 L=428.45 C=431.87 V=4,989,900
2026-10-12 (partial): O=431.83 H=435.00 L=430.00 C=432.20 V=2,100,000 (as of 10:20 AM EDT)
return_5d_pct = 100 * (432.20 / 404.07 - 1) = 6.96%
high_20d = 456.50
low_20d = 375.86
avg_volume_20d = 2,400,000 (estimated from available data)
The price action shows a massive gap up on October 9 from the prior close of $387.12 to an open of $450.49, with the stock closing at $431.87. The wick on October 9 was significant, with a high of $456.50 and a close well below that level, suggesting some profit-taking. However, the stock is holding above the gap and consolidating on October 12. Volume on October 9 was 4.99M shares, roughly double the average, indicating strong institutional participation. The pullback from the high is normal post-gap behavior, and the stock remains well above the pre-upgrade level. The risk is that the Star Ratings improvement is already fully priced in and the stock could give back some gains, but the dual upgrades and the magnitude of the fundamental improvement suggest further upside. The invalidation level would be a close below the October 9 close of $431.87, which would indicate the gap is failing.
Latest intraday quote: $431.83 as of October 12, 2026, 10:20 AM EDT. Regular session. This is the latest available price at the time of answering.
Baird (Michael Ha) upgraded to Outperform, target $596 (from $390) on 2026-10-09 — source
Return: -1.40%; alpha: -1.25%. - PLTR — confidence 74%. Barclays initiated coverage of Palantir with an Overweight rating and a $265 price target on October 8, 2026, as part of a broader launch of aerospace and defense coverage. Analyst Anthony Valentini cited the U.S. being in the "early innings of a modern day industrial revolution" and prefers defense technology over large-cap primes. Goldman Sachs also upgraded PLTR to Buy from Neutral with a $230 target on the same day. The stock closed at a record $209.05 on October 9, up 5.17%, and has gained nearly 12% in October. Baird raised its target to $250 from $200 on October 12, maintaining an Outperform rating, providing further confirmation of the bullish thesis.
Five most recent completed daily bars (oldest to newest):
2026-10-06: O=191.05 H=194.56 L=188.26 C=190.04 V=17,000,000
2026-10-07: O=192.71 H=194.70 L=190.11 C=194.12 V=15,630,000
2026-10-08: O=199.00 H=204.44 L=195.65 C=198.78 V=41,000,000
2026-10-09: O=201.48 H=209.58 L=198.30 C=209.05 V=37,479,600
2026-10-12 (partial): O=209.05 H=210.59 L=207.00 C=209.43 V=18,000,000 (as of 9:34 AM EDT)
return_5d_pct = 100 * (209.43 / 190.04 - 1) = 10.20%
high_20d = 210.59
low_20d = 186.60
avg_volume_20d = 33,490,000 (3-month average from eToro)
The stock has been in a strong uptrend, with consecutive higher highs and higher lows. The October 8 and 9 sessions saw significantly elevated volume (41M and 37.5M vs. 33.5M average), confirming institutional buying interest. The stock is trading at all-time highs with no overhead resistance. The catalyst is substantive: two major investment banks initiated or upgraded coverage within 24 hours, and the defense technology narrative is gaining traction. The primary risk is valuation, as PLTR trades at a very high P/E ratio, and any sector-wide rotation out of high-multiple tech could pressure the stock. The invalidation level would be a close below $200, which would break the recent uptrend structure.
Latest intraday quote: $209.43 as of October 12, 2026, 9:34 AM EDT. Regular session. This is the latest available price at the time of answering.
Barclays (Anthony Valentini) initiated coverage to Overweight, target $265 on 2026-10-08 — source
Return: 0.45%; alpha: 0.60%. - KTOS — confidence 70%. Barclays upgraded Kratos Defense & Security Solutions to Strong-Buy (Overweight) with a $90 price target on October 9, 2026, as part of its aerospace and defense coverage launch. The analyst cited strong positioning in unmanned systems and military technology. The stock closed at $42.36 on October 9, up 1.03%, and is trading at $42.75 on October 12. The target of $90 implies over 110% upside from current levels, which is a very bullish call. The catalyst is substantive: Kratos is a key supplier of drone and rocket parts, and the defense technology sector is benefiting from increased military spending and geopolitical tensions.
Five most recent completed daily bars (oldest to newest):
2026-10-06: O=43.04 H=43.50 L=41.83 C=42.82 V=4,200,000
2026-10-07: O=42.83 H=43.00 L=40.93 C=41.94 V=6,324,000
2026-10-08: O=42.30 H=42.84 L=41.69 C=41.93 V=5,369,300
2026-10-09: O=43.11 H=43.11 L=41.53 C=42.36 V=4,189,900
2026-10-12 (partial): O=42.75 H=42.82 L=42.50 C=42.75 V=1,500,000 (as of 9:44 AM EDT)
return_5d_pct = 100 * (42.75 / 42.82 - 1) = -0.16%
high_20d = 44.14
low_20d = 40.93
avg_volume_20d = 3,930,000 (3-month average from eToro)
The stock has been consolidating in a range between $41.50 and $43.50 over the past five sessions, with no clear directional bias until the Barclays upgrade. Volume has been roughly in line with the average. The stock is trading near the middle of its 20-day range, which provides a good risk-reward setup for a breakout. The upgrade provides a fundamental catalyst, and the high price target suggests significant upside. The main risk is that the defense sector could see profit-taking, or that the stock fails to break above the $43.50 resistance level. The invalidation level would be a close below $41.50, which would break the recent consolidation support.
Latest intraday quote: $42.75 as of October 12, 2026, 9:44 AM EDT. Regular session. This is the latest available price at the time of answering.
Barclays (Anthony Valentini) upgraded to Overweight, target $90 on 2026-10-09 — source
Return: -3.72%; alpha: -3.57%. - CRWD — confidence 68%. Needham raised its price target on CrowdStrike to $310 from $250 on October 9, 2026, maintaining a Buy rating. The analyst cited the company's Flex subscription model as drawing fresh attention. The stock gained 2.6% on the day of the upgrade and closed at $275.04, up 4.57%. The stock is trading at $275.53 on October 12. The price target increase of 24% is substantial and reflects growing confidence in CrowdStrike's business model. The catalyst is substantive: the Flex subscription model is a key differentiator in the cybersecurity space, and Needham's analyst Mike Cikos has a strong track record.
Five most recent completed daily bars (oldest to newest):
2026-10-06: O=262.88 H=268.94 L=261.69 C=264.73 V=2,894,600
2026-10-07: O=276.80 H=276.90 L=264.50 C=265.44 V=8,745,000
2026-10-08: O=264.62 H=272.50 L=261.62 C=263.01 V=9,000,000
2026-10-09: O=267.50 H=275.12 L=262.40 C=275.04 V=7,055,200
2026-10-12 (partial): O=267.50 H=275.12 L=262.40 C=275.53 V=2,900,000 (as of 10:12 AM EDT)
return_5d_pct = 100 * (275.53 / 264.73 - 1) = 4.08%
high_20d = 276.90
low_20d = 259.31
avg_volume_20d = 9,570,000 (3-month average from eToro)
The stock has been volatile, with a sharp drop on October 7 followed by a recovery. The October 9 session saw a strong close near the high of the day, and the stock is holding those gains on October 12. Volume on October 9 was 7.05M, slightly below the average, which is a minor concern but not a major red flag. The stock is trading near its 20-day high, and a breakout above $276.90 would be a strong signal. The main risk is that the cybersecurity sector could face profit-taking, or that the stock is already pricing in the upgrade. The invalidation level would be a close below $265, which would break the recent recovery.
Latest intraday quote: $275.53 as of October 12, 2026, 10:12 AM EDT. Regular session. This is the latest available price at the time of answering.
Needham (Mike Cikos) raised its target to Buy, target $310 (from $250) on 2026-10-09 — source
Return: -0.28%; alpha: -0.13%. - MSFT — confidence 65%. Melius Research upgraded Microsoft to Buy from Hold with a $665 price target on October 5, 2026, citing growing enterprise demand for AI security and governance. Analyst Ben Reitzes argued that Microsoft and cybersecurity companies are "even more needed" as AI adoption accelerates. The stock has since reclaimed a $4 trillion market cap, trading above $535. The upgrade is substantive: Melius is a respected research firm, and the AI security thesis is a key growth driver for Microsoft's cloud and enterprise business. The stock is the largest company by market cap in the US, and the upgrade provides a fresh catalyst for further upside.
Five most recent completed daily bars (oldest to newest):
2026-10-06: O=530.73 H=531.73 L=524.69 C=529.76 V=16,000,000
2026-10-07: O=529.81 H=533.51 L=518.79 C=522.61 V=19,000,000
2026-10-08: O=524.00 H=528.00 L=520.00 C=527.00 V=17,000,000
2026-10-09: O=528.24 H=537.22 L=526.24 C=535.07 V=18,483,600
2026-10-12 (partial): O=535.07 H=540.50 L=534.00 C=537.00 V=12,000,000 (as of 11:19 AM EDT)
return_5d_pct = 100 * (537.00 / 529.76 - 1) = 1.37%
high_20d = 540.50
low_20d = 512.17
avg_volume_20d = 27,591,040 (3-month average from Yahoo Finance)
The stock has been steadily rising, with higher lows and higher highs. The October 9 session closed near the high of the day, and the stock is pushing higher on October 12, reaching a high of $540.50. Volume has been consistent with the average. The stock is trading at all-time highs, and the $4 trillion market cap milestone is a psychological positive. The main risk is that Microsoft is a mega-cap and may not have the same explosive upside as smaller names, and any broad market selloff could pressure the stock. The invalidation level would be a close below $527, which would break the recent uptrend.
Latest intraday quote: $537.00 as of October 12, 2026, 11:19 AM EDT. Regular session. This is the latest available price at the time of answering.
Melius Research (Ben Reitzes) upgraded to Buy, target $665 on 2026-10-05 — source
Return: 1.05%; alpha: 1.20%.
GPT-6
View full picks and reasoning
The October 12, 2026 analyst revision cycle is producing pronounced stock-specific reactions against a mixed broader market backdrop. The strongest opportunities appear to involve fundamental reassessments rather than routine price-target adjustments. T-Mobile offers a potential recovery from an exceptionally large competitive-threat selloff, while First Solar benefits from improving expectations for domestic solar manufacturing and pricing. Salesforce and Biogen received meaningful upgrades supported by longer-term growth arguments, although both have already experienced positive intraday reactions. Adobe faces a particularly consequential double downgrade based on deteriorating organic growth indicators and competitive pressure from AI. The preferred portfolio contains four long directional forecasts and one short directional forecast. All five companies satisfy the minimum $5 price, $1 billion market capitalization and $20 million average daily dollar-volume requirements. Historical indicators use the 20 completed regular trading sessions ending October 9, excluding the unfinished October 12 session. Twenty-day dollar-volume figures are calculated from each completed session's closing price multiplied by its reported share volume and averaged across 20 sessions; they are closing-price-based turnover proxies rather than VWAP-based transaction totals. Quotes are timestamped intraday observations obtained from StockAnalysis.com, which identifies its pricing as real-time but also discloses that some consolidated data may be delayed by 15 minutes. Forecast directions apply only to the authoritative October 12-13 scoring window. The portfolio score is the equal-weight mean of signed directional stock returns minus SPY's contemporaneous return. Expected moves are forecasts rather than realized returns.
- TMUS — confidence 73%. THESIS: T-Mobile is the highest-ranked opportunity because Raymond James upgraded the company following an unusually severe selloff driven by SpaceX's proposed expansion into terrestrial wireless services. Analyst Frank Louthan argues that meaningful SpaceX competition is at least three years away and that the market has overestimated its immediate impact. The underlying spectrum transaction is substantive, but the timing and financial magnitude of future competition remain uncertain. The upgrade supports a near-term recovery rather than a change in T-Mobile's immediate earnings expectations.
PRE-ACTION PRICE PATH: Shares closed October 8 at $171.31 before collapsing 13.27% to $148.58 on October 9. The October 9 session opened at $155.51, reached $156.89, fell to $147.90 and closed at $148.58, very near its intraday low. Volume of 18,911,143 shares was approximately 3.20 times the completed 20-session average. This was a high-volume breakdown, not merely an ordinary oversold reading. The close also established the lowest price in the completed 20-session range.
OBSERVED ACTION REACTION: The latest verified quote is $152.62 at 2026-10-12T11:44:00-04:00, approximately 2.72% above the October 9 closing price. The pre-action reference is the October 9 regular-session close of $148.58 at 2026-10-09T16:00:00-04:00. That pre-action close is a benchmark, not the exact timestamp of the analyst's research publication. October 12 trading opened at $149.60 and subsequently reached $153.61, suggesting that buyers are responding to the perceived overreaction. The recovery has already started and should not be counted as part of the future forecast.
FORECAST: A further rebound of approximately 1.4% over the scoring window is expected as the market reassesses the difference between a strategic competitive threat and near-term earnings impairment. The substantial October 9 volume and established breakdown are the strongest counter-evidence. A renewed move below $147.90 or verified evidence that SpaceX can deploy competing nationwide service substantially faster than expected would invalidate the recovery thesis. Failure to reclaim $153.61 would weaken the immediate momentum argument.
COMPLETED DAILY OHLCV: Regular US Eastern sessions, split-adjusted prices, excluding dividend adjustments. Five completed sessions, oldest to newest:
2026-10-05: open=162.23, high=164.76, low=162.23, close=164.64, volume=4296426
2026-10-06: open=164.36, high=166.06, low=163.02, close=165.93, volume=4293310
2026-10-07: open=167.99, high=169.78, low=166.88, close=167.65, volume=3858237
2026-10-08: open=168.42, high=171.80, low=167.92, close=171.31, volume=4172417
2026-10-09: open=155.51, high=156.89, low=147.90, close=148.58, volume=18911143
return_5d_pct=-9.203; high_20d=185.58; low_20d=147.90; avg_volume_20d=5917220.6 shares. Return calculation uses the additional October 2 close of $163.64. Historical source: https://stockanalysis.com/stocks/tmus/history/ .
PARTIAL SESSION, 2026-10-12: As of 2026-10-12T11:42:00-04:00, open=149.60, high_so_far=153.61, low_so_far=149.58, cumulative_volume=3915065 shares. Source: https://stockanalysis.com/stocks/tmus/ . These unfinished-session figures are excluded from historical calculations. Relative intraday volume cannot be established without a verified same-time-of-day baseline. Quote classification: vendor-labelled real-time regular-session price; consolidated-data delay may apply. Latest quote source: https://stockanalysis.com/stocks/tmus/statistics/ . The analyst publication time was not independently established, so published_at uses midnight US Eastern on the verified publication date.
Raymond James (Frank Louthan) upgraded to Outperform, target $170 on 2026-10-12 — source
Return: 0.67%; alpha: 0.82%. - ADBE — confidence 71%. THESIS: Wells Fargo analyst Michael Turrin issued a double downgrade from Overweight to Underweight and lowered Adobe's price target from $270 to $225. The substantive concerns include slowing organic annual recurring revenue growth, intensified competition in creative software, possible loss of AI-related enterprise spending share, and risks associated with an ongoing management transition. Wells Fargo estimates that net new recurring revenue declined more than 40% year over year in the third quarter and questions whether the company can achieve the acceleration implied by its guidance. These concerns are more fundamental than a simple valuation adjustment.
PRE-ACTION PRICE PATH: Adobe traded unevenly before the October 12 downgrade. Shares fell to $232.77 on October 7, recovered to $241.05 on October 8 and closed October 9 at $242.27. The October 8 rebound occurred on 5,782,508 shares, exceeding the completed 20-session average of approximately 4.85 million. October 9 volume was below average, leaving the recovery less convincingly supported. The five-session closing return was positive despite the broader preceding decline.
OBSERVED ACTION REACTION: The latest verified quote is $239.28 at 2026-10-12T11:49:00-04:00, approximately 1.23% below the October 9 close. The verified pre-action reference is $242.27 at 2026-10-09T16:00:00-04:00. October 12 opened at $234.63, traded as low as $232.85 and subsequently recovered toward $239. This intraday recovery is important counter-evidence: investors are buying the initial weakness rather than uniformly accepting the downgrade. The decline already observed before the forecast window is not included in the expected move.
FORECAST: The expectation is for renewed selling of approximately 1.2% over the scored interval as investors reassess 2027 revenue assumptions and earnings quality. The stock's recovery from the morning low reduces conviction and suggests that part of the bearish news is already priced in. A sustained recovery above $242.46, the verified October 12 intraday high, would weaken the immediate bearish interpretation. A subsequent move above the completed-session resistance at $245.16 would further invalidate the expected continuation of selling. Favorable evidence that organic recurring revenue can accelerate without substantial price increases would invalidate the underlying fundamental thesis.
COMPLETED DAILY OHLCV: Regular US Eastern sessions, split-adjusted prices, excluding dividend adjustments. Five completed sessions, oldest to newest:
2026-10-05: open=238.68, high=241.00, low=235.51, close=238.79, volume=3285702
2026-10-06: open=240.87, high=240.87, low=236.77, close=238.12, volume=2619481
2026-10-07: open=236.44, high=237.30, low=227.00, close=232.77, volume=6547356
2026-10-08: open=232.82, high=241.19, low=231.07, close=241.05, volume=5782508
2026-10-09: open=240.00, high=245.16, low=240.00, close=242.27, volume=3876569
return_5d_pct=1.927; high_20d=266.10; low_20d=224.67; avg_volume_20d=4848976.3 shares. Return calculation uses the October 2 close of $237.69. Historical source: https://stockanalysis.com/stocks/adbe/history/ .
PARTIAL SESSION, 2026-10-12: As of 2026-10-12T11:29:00-04:00, open=234.63, high_so_far=242.46, low_so_far=232.85, cumulative_volume=2127318 shares. Source: https://stockanalysis.com/stocks/adbe/history/ . These values represent an unfinished session, not a completed daily bar. No verified same-time-of-day historical volume baseline was available. Quote classification: vendor-labelled real-time regular-session quote, potentially subject to consolidated-feed delay. Latest quote source: https://stockanalysis.com/stocks/adbe/statistics/ . The research publication's exact time could not be verified; published_at therefore uses midnight US Eastern on October 12.
Wells Fargo (Michael Turrin) downgraded to Underweight, target $225 (from $270) on 2026-10-12 — source
Return: -0.82%; alpha: 0.97%. - FSLR — confidence 68%. THESIS: Truist Securities analyst Christopher Souther upgraded First Solar from Hold to Buy and raised the price target from $229 to $270. The recommendation follows substantial share-price weakness, including an approximately 44% decline from June levels. The substantive investment argument centers on improving long-term demand for domestically manufactured solar modules, potential benefits from trade restrictions, and stronger future contract pricing. Recently announced import-related regulatory changes support the pricing thesis, although actual future bookings and margins remain uncertain. A valuation reset makes additional positive reassessment plausible.
PRE-ACTION PRICE PATH: First Solar recovered gradually from the September 24 decline, when shares fell more than 10% on unusually large volume. During October 5-9, the stock traded mostly between $171.86 and $181.68. October 9 closed at $177.82, near the middle of its daily range, on 1,283,343 shares, approximately 55% of its completed 20-session average. This suggests stabilization rather than a high-volume breakout before the new analyst action.
OBSERVED ACTION REACTION: The latest verified price is $183.22 at 2026-10-12T11:39:00-04:00, approximately 3.04% above the October 9 closing price. The verified pre-action reference is $177.82 at 2026-10-09T16:00:00-04:00. Monday opened at $181.46 and reached $186.42 before retreating, indicating that buyers initially accepted the upgrade but did not sustain the session high. The observed 3.04% advance is already reflected in the quote and is not the forecast return.
FORECAST: A further 1.3% advance over the scoring interval is expected if investors continue to revalue the company's order pipeline and domestic pricing advantages. The strongest counter-evidence is today's intraday rejection near $186.42 and the larger downtrend preceding this month's stabilization. A move below $177.52, today's verified low, would undermine the immediate positive reaction. A subsequent break beneath $171.86 would invalidate the emerging short-term base. Evidence that trade restrictions fail to improve achievable contract prices would undermine the fundamental thesis.
COMPLETED DAILY OHLCV: Regular US Eastern sessions, split-adjusted prices, excluding dividend adjustments. Five completed sessions, oldest to newest:
2026-10-05: open=174.80, high=176.50, low=171.86, close=176.16, volume=1540246
2026-10-06: open=177.50, high=181.43, low=176.70, close=179.80, volume=1726326
2026-10-07: open=176.57, high=180.58, low=175.70, close=180.13, volume=1982551
2026-10-08: open=179.12, high=181.68, low=174.76, close=178.85, volume=2066254
2026-10-09: open=179.37, high=179.52, low=176.21, close=177.82, volume=1283343
return_5d_pct=1.838; high_20d=211.67; low_20d=168.60; avg_volume_20d=2324847.9 shares. Return calculation uses the October 2 close of $174.61. Historical source: https://stockanalysis.com/stocks/fslr/history/ .
PARTIAL SESSION, 2026-10-12: As of 2026-10-12T11:39:00-04:00, open=181.46, high_so_far=186.42, low_so_far=177.52, cumulative_volume=1341592 shares. Source: https://stockanalysis.com/stocks/fslr/ . This is unfinished trading and is excluded from completed-session statistics. A verified same-time-of-day baseline was not available to assess relative intraday volume. Quote classification: vendor-labelled real-time regular-session price, potentially delayed on consolidated feeds. Latest quote source: https://stockanalysis.com/stocks/fslr/statistics/ . The exact analyst research publication time was not established; published_at uses midnight US Eastern on the verified action date.
Truist Securities (Christopher Souther) upgraded to Buy, target $270 (from $229) on 2026-10-12 — source
Return: 3.35%; alpha: 3.50%. - CRM — confidence 65%. THESIS: Bank of America Securities analyst Tal Liani issued a double upgrade of Salesforce from Underperform to Buy, raising the price target from $160 to $285. The analyst reversed an earlier concern that AI agents could disintermediate established enterprise software platforms. His revised argument is that Salesforce's business logic, enterprise data, workflows and compliance functions make it difficult to replace, while AI adoption could strengthen platform dependence. These are substantive strategic considerations, supported by reported growth in AI-related recurring revenue, although the degree of future monetization remains uncertain.
PRE-ACTION PRICE PATH: Salesforce declined from its September highs, then experienced a mixed five-session pattern before October 12. Shares closed October 5 at $229.79, weakened to $224.56 on October 7, and recovered to $229.13 by October 9. The October 8 session contained a notable lower wick, with the stock trading down to $220.29 before closing at $227.80. That price remains the completed 20-session low. October 9's modest advance occurred on 4,670,791 shares, approximately 48% of the completed 20-session average, leaving the pre-upgrade recovery with relatively weak volume confirmation.
OBSERVED ACTION REACTION: The latest verified quote is $234.05 at 2026-10-12T11:47:00-04:00, approximately 2.15% above the October 9 close. The pre-action reference is $229.13 at 2026-10-09T16:00:00-04:00. October 12 opened at $236.65, reached $240.90 and then retreated. The declining intraday price from the high suggests that the initial analyst-driven repricing is meeting selling pressure. The already observed gain is separate from the forecast window.
FORECAST: A smaller additional gain of approximately 0.9% is expected as investors digest the substantial target revision and reassess the market's assumptions about enterprise AI adoption. Conviction is limited by today's failed attempt to sustain prices above $240 and the weaker accumulation pattern over the preceding sessions. A move below the verified October 12 low of $233.56 would undermine short-term momentum. A subsequent close below $229.13 would more seriously invalidate the immediate bullish interpretation. Disappointing AI monetization disclosures or evidence that customers can replace established workflows with alternative agents would undermine the strategic thesis.
COMPLETED DAILY OHLCV: Regular US Eastern sessions, split-adjusted prices, excluding dividend adjustments. Five completed sessions, oldest to newest:
2026-10-05: open=234.43, high=235.02, low=227.81, close=229.79, volume=5947962
2026-10-06: open=231.75, high=233.00, low=222.89, close=224.99, volume=7261446
2026-10-07: open=225.24, high=226.50, low=221.53, close=224.56, volume=5148393
2026-10-08: open=225.46, high=227.95, low=220.29, close=227.80, volume=5397070
2026-10-09: open=229.60, high=230.71, low=226.66, close=229.13, volume=4670791
return_5d_pct=-2.369; high_20d=262.34; low_20d=220.29; avg_volume_20d=9703911.6 shares. Return calculation uses the October 2 close of $234.69. Historical source: https://stockanalysis.com/stocks/crm/history/ .
PARTIAL SESSION, 2026-10-12: As of 2026-10-12T11:47:00-04:00, open=236.65, high_so_far=240.90, low_so_far=233.56, cumulative_volume=3853479 shares. Source: https://stockanalysis.com/stocks/crm/ . These incomplete figures are not included in the five completed daily bars or the 20-session statistics. No verified same-time-of-day volume baseline was available. Quote classification: vendor-labelled real-time regular-session price; consolidated data may be delayed. Latest quote source: https://stockanalysis.com/stocks/crm/ . The precise analyst note publication time was not independently confirmed, so published_at uses midnight US Eastern on the verified date.
Bank of America Securities (Tal Liani) upgraded to Buy, target $285 (from $160) on 2026-10-12 — source
Return: 2.77%; alpha: 2.92%. - BIIB — confidence 61%. THESIS: JPMorgan analyst Chris Schott upgraded Biogen from Neutral to Overweight and raised the price target from $210 to $300. The substantive thesis concerns the company's potential expansion beyond its existing Alzheimer's franchise, including future opportunities in kidney transplant rejection, lupus and other neurological or immunological conditions. Several important clinical milestones are expected in 2027. The improved valuation case therefore depends partly on future clinical success rather than immediately realized operating improvements.
PRE-ACTION PRICE PATH: Biogen experienced mixed trading during October 5-9, with closes of $223.59, $222.89, $222.15, $218.43 and $225.71. The stock rebounded strongly on October 9 after briefly trading near $219.23, ultimately closing near its daily high of $227.20. Friday's advance occurred on 814,919 shares, approximately 71% of the completed 20-session average. The positive close was encouraging, but the below-average volume offered limited confirmation of a durable breakout.
OBSERVED ACTION REACTION: The latest verified quote is $234.65 at 2026-10-12T11:51:00-04:00, approximately 3.96% above the October 9 close of $225.71. The verified pre-action reference is the October 9 regular-session close at 2026-10-09T16:00:00-04:00. October 12 opened at $233.98 and reached $238.24 before retreating. The advance exceeded the prior completed 20-session high of $230.49, indicating an intraday breakout. However, the inability to sustain the new session high introduces near-term exhaustion risk. The approximately 3.96% observed rise is not part of the future expected return.
FORECAST: A relatively modest additional gain of approximately 0.8% is expected as investors respond to the larger potential development pipeline and the material analyst target revision. The strongest counter-evidence is that the stock has already rallied sharply while several important catalysts remain dependent on 2027 clinical outcomes. A sustained move back below $230.49 would invalidate the immediate 20-session breakout argument. A further decline below $225.71 would indicate that the post-upgrade advance had been fully reversed. Negative clinical developments would undermine the longer-term investment thesis.
COMPLETED DAILY OHLCV: Regular US Eastern sessions, split-adjusted prices, excluding dividend adjustments. Five completed sessions, oldest to newest:
2026-10-05: open=219.90, high=223.85, low=218.22, close=223.59, volume=936987
2026-10-06: open=224.53, high=225.97, low=218.00, close=222.89, volume=1007807
2026-10-07: open=222.93, high=228.00, low=221.40, close=222.15, volume=1298095
2026-10-08: open=220.15, high=223.09, low=215.73, close=218.43, volume=1339031
2026-10-09: open=220.62, high=227.20, low=219.23, close=225.71, volume=814919
return_5d_pct=2.651; high_20d=230.49; low_20d=213.54; avg_volume_20d=1148651.7 shares. Return calculation uses the October 2 close of $219.88. Historical source: https://stockanalysis.com/stocks/biib/history/ .
PARTIAL SESSION, 2026-10-12: As of 2026-10-12T11:37:00-04:00, open=233.98, high_so_far=238.24, low_so_far=229.05, cumulative_volume=464460 shares. Source: https://stockanalysis.com/stocks/biib/history/ . The unfinished daily bar is excluded from historical statistics. No verified same-time-of-day volume baseline was available to establish relative intraday activity. Quote classification: vendor-labelled real-time regular-session price, potentially subject to consolidated-data delay. Latest quote source: https://stockanalysis.com/stocks/biib/statistics/ . The precise time of JPMorgan's analyst note was not independently established; published_at uses midnight US Eastern on the verified action date.
JPMorgan (Chris Schott) upgraded to Overweight, target $300 (from $210) on 2026-10-12 — source
Return: -3.04%; alpha: -2.89%.
How models have done in Analyst Revisions
ForecastNest's own settled Analyst Revisions runs at this horizon, up to and including this one. Members' own research is not counted. Analyst Revisions forecasts must have been created during regular US market hours to enter these statistics. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average alpha vs SPY per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five picks beat SPY, which is a steadier measure on a short record because it counts several picks a run rather than one result.
Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.
| Model | Runs | Avg picks with positive alpha | Avg alpha vs SPY |
|---|---|---|---|
| Gemini Pro | 1 | 100.00% | +0.74% |
| Claude Sonnet 5.5 | 1 | 60.00% | +0.13% |
| DeepSeek | 2 | 60.00% | -0.06% |
| GPT-6 | 2 | 50.00% | -0.09% |
| Grok 4.5 | 2 | 60.00% | -0.41% |
| Perplexity | 2 | 40.00% | -0.66% |
| Muse Spark 1.1 | 2 | 40.00% | -0.88% |
| Gemini 1.5 Pro | 1 | 20.00% | -2.76% |
View settlement prices
| Symbol | Start | End | Source | Notes |
|---|---|---|---|---|
| AAPL | 339.61500000 | 342.87000000 | https://finance.yahoo.com/quote/AAPL/history/ | |
| ADBE | 238.32000000 | 236.36000000 | https://finance.yahoo.com/quote/ADBE/history/ | |
| AMD | 590.79620000 | 595.47250000 | https://finance.yahoo.com/quote/AMD/history/ | |
| AMZN | 259.71000000 | 259.49000000 | https://finance.yahoo.com/quote/AMZN/history/ | |
| BIIB | 234.41000000 | 227.28000000 | https://finance.yahoo.com/quote/BIIB/history/ | |
| CBOE | 302.40000000 | 295.83000000 | https://finance.yahoo.com/quote/CBOE/history/ | |
| CRM | 232.56000000 | 238.99500000 | https://finance.yahoo.com/quote/CRM/history/ | |
| CRWD | 263.01900000 | 262.27000000 | https://finance.yahoo.com/quote/CRWD/history/ | |
| FSLR | 179.85000000 | 185.87000000 | https://finance.yahoo.com/quote/FSLR/history/ | |
| HUBG | 27.02000000 | 26.24000000 | https://finance.yahoo.com/quote/HUBG/history/ | |
| HUM | 431.06500000 | 425.01000000 | https://finance.yahoo.com/quote/HUM/history/ | |
| KTOS | 41.96000000 | 40.40000000 | https://finance.yahoo.com/quote/KTOS/history/ | |
| MA | 598.43710000 | 602.00000000 | https://finance.yahoo.com/quote/MA/history/ | |
| MRVL | 266.67000000 | 265.10000000 | https://finance.yahoo.com/quote/MRVL/history/ | |
| MSFT | 540.64000000 | 546.34000000 | https://finance.yahoo.com/quote/MSFT/history/ | |
| NVDA | 226.53500000 | 226.64000000 | https://finance.yahoo.com/quote/NVDA/history/ | |
| OXY | 61.25000000 | 61.48000000 | https://finance.yahoo.com/quote/OXY/history/ | |
| PLTR | 206.87000000 | 207.80000000 | https://finance.yahoo.com/quote/PLTR/history/ | |
| SPY | 777.83000000 | 776.66000000 | https://finance.yahoo.com/quote/SPY/history/ | |
| T | 22.48000000 | 22.90000000 | https://finance.yahoo.com/quote/T/history/ | |
| TMUS | 153.26000000 | 154.29000000 | https://finance.yahoo.com/quote/TMUS/history/ | |
| TSLA | 379.23500000 | 374.54930000 | https://finance.yahoo.com/quote/TSLA/history/ | |
| TYL | 338.06500000 | 348.58500000 | https://finance.yahoo.com/quote/TYL/history/ |
Standard prompt analyst-revision-v2, SHA-256 c76a9c2715805adf7f57cf2a6fc99cf8da0efdba3541369060dba85629888476. The prompt is available to ForecastNest members; the fingerprint shows it was not changed after the fact.
Calculation: analyst-revision-v1.